Taylor Michael J, Garrard Tara A, O'Donahoo Francis J, Ross Kirstin E
Health and Environment, School of the Environment, Flinders University, Adelaide, SA, Australia.
Res Rep Trop Med. 2014 Aug 20;5:55-63. doi: 10.2147/RRTM.S63138. eCollection 2014.
is a human parasitic nematode that is poorly understood outside a clinical context. This article identifies gaps within the literature, with particular emphasis on gaps that are hindering environmental control of . The prevalence and distribution of is unclear. An estimate of 100-370 million people infected worldwide has been proposed; however, inaccuracy of diagnosis, unreliability of prevalence mapping, and the fact that strongyloidiasis remains a neglected disease suggest that the higher figure of more than 300 million cases is likely to be a more accurate estimate. The complexity of life cycle means that laboratory cultures cannot be maintained outside of a host. This currently limits the range of laboratory-based research, which is vital to controlling through environmental alteration or treatment. Successful clinical treatment with antihelminthic drugs has meant that controlling through environmental control, rather than clinical intervention, has been largely overlooked. These control measures may encompass alteration of the soil environment through physical means, such as desiccation or removal of nutrients, or through chemical or biological agents. Repeated antihelminthic treatment of individuals with recurrent strongyloidiasis has not been observed to result in the selection of resistant strains; however, this has not been explicitly demonstrated, and relying on such assumptions in the long-term may prove to be shortsighted. It is ultimately naive to assume that continued administration of antihelminthics will be without any negative long-term effects. In Australia, strongyloidiasis primarily affects Indigenous communities, including communities from arid central Australia. This suggests that the range of extends beyond the reported tropical/subtropical boundary. Localized conditions that might result in this extended boundary include accumulation of moisture within housing because of malfunctioning health hardware inside and outside the house and the presence of dog fecal matter inside or outside housing areas.
是一种人体寄生线虫,在临床背景之外人们对其了解甚少。本文指出了文献中的空白,特别强调了阻碍其环境控制的空白。粪类圆线虫的流行率和分布情况尚不清楚。有人提出全球感染人数估计为1亿至3.7亿;然而,诊断的不准确、流行率绘图的不可靠,以及粪类圆线虫病仍是一种被忽视疾病这一事实表明,超过3亿例的较高数字可能是更准确的估计。粪类圆线虫生命周期的复杂性意味着无法在宿主之外维持实验室培养。这目前限制了基于实验室的研究范围,而这种研究对于通过环境改变或治疗来控制粪类圆线虫至关重要。抗蠕虫药物的成功临床治疗意味着通过环境控制而非临床干预来控制粪类圆线虫在很大程度上被忽视了。这些控制措施可能包括通过物理手段改变土壤环境,如干燥或去除养分,或通过化学或生物制剂。尚未观察到对复发性粪类圆线虫病患者进行反复抗蠕虫治疗会导致耐药菌株的产生;然而,这一点尚未得到明确证明,长期依赖此类假设可能被证明是目光短浅的。假设持续使用抗蠕虫药物不会产生任何长期负面影响最终是幼稚的。在澳大利亚,粪类圆线虫病主要影响原住民社区,包括澳大利亚中部干旱地区的社区。这表明粪类圆线虫的分布范围超出了报告的热带/亚热带边界。可能导致这种扩展边界的局部条件包括房屋内外卫生设施故障导致房屋内水分积聚,以及房屋区域内外存在狗粪便。